Abstract
Past research suggests a relationship between stress and positive symptoms of psychosis. However, the biological substrate of this relationship remains unknown. According to the transmethylation hypothesis, schizophrenia could result from a biochemical disruption in the stress mechanism. This biochemical disruption would lead to the production of a substance that would account for the symptoms of psychosis. Moreover, some studies have tested endogenous N,N-dimethyltryptamine (DMT) in the context of the transmethylation hypothesis. Stress has been found to elevate DMT levels in rodents. Also, elevated DMT levels have been associated with positive features of psychosis in psychiatric patients. Additionally, healthy participants treated with exogenous DMT experience predominantly positive symptoms of psychosis. The present paper examines endogenous DMT as a possible biological mediator of the relationship between stress and positive symptoms of psychosis.
Similar content being viewed by others
References
Barker S, Monti J, Christian S (1981) N,N-dimethyltryptamine: an endogenous hallucinogen. Int Rev Neurobiol 22:83–110
Barker S, McIlhenny E, Strassman R (2012) A critical review of reports of endogenous psychedelic N,N-dimethyltryptamines in humans: 1955–2010. Drug Test Anal 4(7–8):617–635. doi:10.1002/dta.422
Bøgesø KP, Bang-Andersen B (2003) Dopamine and serotonin receptor and transporter ligands. In: Liljefors T, Krogsgaard-Larsen P, Madsen U (eds) Textbook of drug design and discovery, 3rd edn. CRC Press, Florida, pp 336–367
Böszörményi ZZ, St Szára (1958) Dimethyltryptamine experiments with psychotics. J Ment Sci 104(435):445–453
Bracht T, Horn H, Strik W et al (2014) White matter pathway organization of the reward system is related to positive and negative symptoms in schizophrenia. Schizophr Res 153(1–3):136–142
Bunzow J, Sonders M, Arttamangkul S et al (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60(6):1181–1188
Callaway JC, Airaksinen MM, McKenna DJ, Brito GS, Grob CS (1994) Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116(3):385–387. doi:10.1007/BF02245347
Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX (2007) Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Psychopharmacology 195(3):415–424. doi:10.1007/s00213-007-0930-9
Collip D, Nicolson NA, Lardinois M, Lataster T, Van Os J, Myin-Germeys I (2011) Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol Med 41(11):2305–2315
Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116(12):1591–1599. doi:10.1007/s00702-009-0308-8
Cozzi NV, Mavlyutov TA, Thompson MA, Ruoho AE (2011) Indolethylamine N-methyltransferase expression in primate nervous tissue. Soc Neurosci Abstr 37(840):19
Craig AD (2009) Disembodied hallucinatory voices: comment on Sommer et al., 2008. Brain 132(10). doi:10.1093/brain/awp038
Curzon G, Joseph M, Knott P (1972) Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem 19(8):1967–1974
Deliganis A, Pierce P, Peroutka S (1991) Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. Biochem Pharmacol 41(11):1739–1744
Doyle AA, Hucklebridge FF, Evans PP, Clow AA (1996) Urinary output of endogenous monoamine oxidase inhibitory activity is related to everyday stress. Life Sci 58(20):1723–1730. doi:10.1016/0024-3205(96)00153-1
Fontanilla D, Johannessen M, Hajipour A, Cozzi N, Jackson M, Ruoho A (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323(5916):934–937. doi:10.1126/science.1166127
González-Maeso J, Weisstaub N, Zhou M et al (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53(3):439–452
Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar K (2005) Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38(6):301–311
Govitrapong P, Mukda S, Turakitwanakan W, Dumrongphol H, Chindaduangratn C, Sanvarinda Y (2002) Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment. Neurochem Int 41(4):209–216
Harrison REW, Christian ST (1984) Individual housing stress elevates brain and adrenal tryptamine content. In: Boulton AA (ed) Neurobiology of the trace amines. Humana Press, New Jersey, pp 249–255
Haubrich D, Wang P (1977) N’N-dimethyltryptamine lowers rat brain acetylcholine and dopamine. Brain Res 131(1):158–161
Horga G, Fernández-Egea E, Mané A et al (2014) Brain metabolism during hallucination-like auditory stimulation in schizophrenia. PLoS One 9(1):1–9. doi:10.1371/journal.pone.0084987
Jacob M, Presti D (2005) Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Med Hypotheses 64(5):930–937
Jenner P, Marsden C, Thanki C (1978) Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings]. Br J Pharmacol 63(2):380
Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13–23
Lataster TT, Valmaggia LL, Lardinois MM, van Os JJ, Myin-Germeys II (2013) Increased stress reactivity: a mechanism specifically associated with the positive symptoms of psychotic disorder. Psychol Med 43(7):1389–1400. doi:10.1017/S0033291712002279
Matsumoto R, Pouw B (2000) Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions. Eur J Pharmacol 401(2):155–160
Meltzer H, Massey B, Horiguchi M (2012) Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. Curr Pharm Biotechnol 13(8):1572–1586
Mizrahi R et al (2012) Increased stress-induced dopamine release in psychosis. Biol Psychiatry 71(6):561–567
Murray R, Oon M, Rodnight R, Birley J, Smith A (1979) Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association. Arch Gen Psychiatry 36(6):644–649
Myin-Germeys I, van Os J (2007) Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 27(4):409–424. doi:10.1016/j.cpr.2006.09.005
Myin-Germeys II, Delespaul Ph, van Os JJ (2005) Behavioural sensitization to daily life stress in psychosis. Psychol Med 35(5):733–741. doi:10.1017/S0033291704004179
Osmond H, Smythies J (1952) Schizophrenia: a new approach. J Ment Sci 98:309–315
Palaniyappan L, Liddle PF (2012) Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci 37(1):17–27. doi:10.1503/jpn.100176
Palaniyappan LL, Mallikarjun PP, Joseph VV, White TP, Liddle PF (2011) Reality distortion is related to the structure of the salience network in schizophrenia. Psychol Med 41(8):1701–1708. doi:10.1017/S0033291710002205
Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS (2006) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31(2):265–277. doi:10.1038/sj.npp.1300819
Pomilio A, Vitale A, Ciprian-Ollivier J, Cetkovich-Bakmas M, Gómez R, Vázquez G (1999) Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J Ethnopharmacol 65(1):29–51
Riba J, Romero S, Grasa E, Mena E, Carrió I, Barbanoj M (2006) Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. Psychopharmacology 186(1):93–98. doi:10.1007/s00213-006-0358-7
Siegel R (1984) Hostage hallucinations. Visual imagery induced by isolation and life-threatening stress. J Nerv Ment Dis 172(5):264–272
Smith TL (1977) Increased synthesis of striatal dopamine by N,N-dimethyltryptamine. Life Sci 21(11):1597–1601
Smith R, Canton H, Barrett R, Sanders-Bush E (1998) Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav 61(3):323–330
Sommer I et al (2008) Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain 131(12):3169–3177. doi:10.1093/brain/awn251
Spatz N, Spatz H, Mesones Arroyo H, Rosan T, Brengio F (1993) Elimination of N,N-dimethyltryptamine by urine. Acta Psiquiatr Psicol Am Lat 39(3):212–216
Strahilevitz M, Narasimhachari N, Fischer G, Meltzer H, Himwich H (1975) Indolethylamine-N-methyltransferase activity in psychiatric patients and controls. Biol Psychiatry 10(3):287–302
Strassman RJ, Qualls CR (1994) Dose-response study of N,N-dimethyltryptamine in humans: I. neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 51(2):85–97
Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose-response study of N,N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51(2):98–108. doi:10.1001/archpsyc.1994.03950020022002
Su T, Hayashi T, Vaupel D (2009) When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal 2(61):12. doi:10.1126/scisignal.261pe12
Taylor SF, Liberzon I, Decker LR, Koeppe RA (2002) A functional anatomic study of emotion in schizophrenia. Schizophr Res 58(2–3):159–172. doi:10.1016/S0920-9964(01)00403-0
Thompson M, Moon E, Kim U, Xu J, Siciliano M, Weinshilboum R (1999) Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics 61(3):285–297
Tillinger A, Sollas A, Serova LI, Kvetnansky R, Sabban EL (2010) Vesicular monoamine transporters (VMATs) in adrenal chromaffin cells: stress-triggered induction of VMAT2 and expression in epinephrine synthesizing cells. Cell Mol Neurobiol 30(8):1459–1465. doi:10.1007/s10571-010-9575-z
Uebelhack R, Franke L, Seidel K (1983) Methylated and unmethylated indolamine in the cisternal fluid in acute endogenous psychoses. Biomed Biochim Acta 42(10):1343–1346
Vitale AA, Ollivier JC, Vitale V, Romero E, Pomillo AB (2010) Estudio clínico de marcadores de hipermetilación indólica en las alteraciones de la percepción. Acta Bioquím Clín Latinoam 44(4):627–642. ISSN 0325-2957. http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-29572010000400003&lng=es&nrm=iso. Accessed 26 November 2013
Vitale A, Pomilio A, Cañellas C, Vitale M, Putz E, Ciprian-Ollivier J (2011) In vivo long-term kinetics of radiolabeled N,N-dimethyltryptamine and tryptamine. J Nucl Med 52(6):970–977. doi:10.2967/jnumed.110.083246
Waldmeier P, Maître L (1977) Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain. Psychopharmacology 52(2):137–144
Wallach JV (2009) Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. Med Hypotheses 72(1):91–94
Warren JM, Dham-Nayyar P, Alexander J (2013) Recreational use of naturally occurring dimethyltryptamine—contributing to psychosis? Aust N Z J Psychiatry 47(4):398–399
Wyatt R, Saavedra JM, Belmaker R, Cohen S, Pollin W (1973) The dimethyltryptamine-forming enzyme in blood platelets: a study in monozygotic twins discordant for schizophrenia. Am J Psychiatry 130(12):1359–1361
Zucker M, Valevski A, Weizman A, Rehavi M (2002) Increased platelet vesicular monoamine transporter density in adult schizophrenia patients. Eur Neuropsychopharmacol 12(4):343–347
Zureick JL, Meltzer HY (1988) Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis. Biol Psychiatry 24(1):63–78. doi:10.1016/0006-3223(88)90122-9
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grammenos, D., Barker, S.A. On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis. J Neural Transm 122, 733–739 (2015). https://doi.org/10.1007/s00702-014-1329-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-014-1329-5